FDA panel backs wider use of Eli Lilly's Cymbalta - Reuters

[INCIID News Feed]

Kansas City Star
<img alt="" height="1" width="1" />
FDA panel backs wider use of Eli Lilly&#39;s Cymbalta
Reuters
BETHESDA, Md., Aug 19 (Reuters) - Eli Lilly and Co&#39;s (LLY.N) antidepressant Cymbalta should be approved to help ease chronic pain in certain patients, a US medical advisory panel said on Thursday. A US Food and Drug Administration panel ...
Lilly Wins FDA Panel&#39;s Backing for Broader Cymbalta Use in Knee, Back PainBloomberg
FDA panel mixed on approving Cymbalta for painThe Associated Press
Cymbalta Under FDA Review for Chronic PainABC News
MedPage Today -Wall Street Journal -Zacks.com
all 353 news articles &raquo;


More...